SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Crypto is experiencing intense community engagement, fueled by calls to embrace 'OG meme SZN' and the timeless appeal of Rage Comics. The highly convicted community is actively defending its market value and anticipating significant upside, with discussions frequently mentioning potential major exchange listings and a mission to onboard a million users.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending strongly amid news of cannabis reclassification to Schedule III, a development sparking significant excitement across the broader cannabis and crypto sectors. The community, which identifies as a global cannabis movement built on Solana, is actively discussing its 'culture is forever' ethos and the potential for the asset to go 'way higher,' positioning itself as a leader in the green revolution.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

FLGC is trending due to its strategic rebrand as ZeroStack, pivoting to Decentralized AI and a significant crypto treasury strategy, reportedly holding $100M in 0G tokens against a much smaller market capitalization. The community is actively discussing this low-float stock's potential for a substantial short squeeze, further amplified by shareholder approval for a future forward stock split, signaling confidence in significant upside. This narrative, combined with its existing cannabis operations, is driving strong speculative interest.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is trending after reporting strong revenue and earnings that surpassed estimates, coupled with management's optimistic outlook for accelerating growth in upcoming periods. This has sparked intense debate, with bulls asserting the stock is deeply undervalued and ripe for a short squeeze due to high institutional ownership, while bears express skepticism over management and concerns about slowing policy-in-force expansion amidst improving financials. The discussion highlights the broader challenge for the insurtech to translate its operational turnaround into sustained market appreciation.

BlackRock Institutional Trust Company N.A. - iShares China Large-Cap ETF

iShares China Large-Cap ETF

iShares China Large-Cap ETF (FXI) is a key focus as renewed speculation around U.S.-China trade relations and potential tariff adjustments drives significant debate among investors. The market is weighing optimistic projections for a "mega rally" due to anticipated policy easing against persistent concerns regarding China's economic fundamentals, including property sector challenges and consumer demand. This dynamic situation is fueling active discussion and a divided outlook on China's large-cap equities.

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

Cytokinetics is trending following FDA approval for MYQORZO (aficamten) to treat obstructive hypertrophic cardiomyopathy, an event many in the community viewed as largely priced in. While a black box warning is noted, significant discussion revolves around its potentially differentiated and more flexible administration compared to competitor Camzyos. The community is actively debating the drug's launch trajectory and its potential to become a leading treatment in the evolving market for this cardiac condition.

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of beverages, food, and snacks. It operates through the following business segments: Frito-Lay North America (FLNA), Quaker Foods North America (QFNA), PepsiCo Beverages North America (PBNA), Latin America (LatAm), Europe, Africa, Middle East, and South Asia (AMESA), and Asia Pacific, Australia and New Zealand, and China Region (APAC). The FLNA segment consists of branded convenient food businesses in the United States and Canada. The QFNA segment includes cereals, rice, and pasta under the Quaker, Pearl Milling Company, Quaker Chewy, Cap'n Crunch, Life, and Rice-A-Roni brands. The PBNA segment is composed of beverage concentrates, fountain syrups, and finished goods under various beverage brands such as Pepsi, Gatorade, Mountain Dew, Diet Pepsi, Aquafina, Diet Mountain Dew, Sierra Mist, and Mug. The LatAm segment covers beverage, food, and snack businesses in the Latin American region. The Europe segment offers beverage, food, and snack goods in Europe and Sub-Saharan Africa regions. The AMESA segment deals with all beverage and convenient food businesses in Africa, the Middle East, and South Asia. The APAC segment refers to all business operations in the Asia Pacific, Australia and New Zealand, and China region. The company was founded by Donald M. Kendall, Sr. and Herman W. Lay in 1965 and is headquartered in Purchase, NY.

PepsiCo Inc

PepsiCo is trending as activist investor Elliott Management's influence prompts a strategic overhaul, including SKU reductions, cost cuts, and leadership changes aimed at enhancing efficiency and profitability. This restructuring, coupled with recent analyst upgrades and speculation around potential new beverage market opportunities, is fueling community discussion on PepsiCo's long-term growth trajectory. While some investors anticipate renewed margin expansion and stable returns, others remain cautious about the impact of these changes on pricing strategy and volume growth amidst an evolving consumer staples market.

EPAM Systems, Inc. engages in the provision of digital engineering, cloud, and artificial intelligence-enabled transformation services. The firm combines software engineering with customer experience design, business consulting, strategy, and technology innovation services in areas such as cloud platforms, cybersecurity, and artificial intelligence. It operates through the North America and Europe geographical segments. The company was founded by Leonid Lozner and Arkadiy Dobkin in 1993 and is headquartered in Newtown, PA.

EPAM Systems Inc

EPAM Systems is trending due to strong quarterly earnings that surpassed estimates, coupled with optimistic guidance and a newly announced stock repurchase program. The community is actively discussing the company's robust fundamentals and AI-driven innovations, seeing it as a potential beneficiary from digital transformation trends and improved geopolitical stability. While many anticipate further upside, some traders are noting overbought conditions and suggesting caution for short-term movements.

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings is experiencing significant market attention, driven by frequent trade alerts highlighting potential reversals from oversold conditions and a wave of updated analyst ratings reflecting varied outlooks. The company's strategic focus on innovation, including recent FDA clearances for robotic knee and shoulder systems and key acquisitions, is being weighed against a lowered profit forecast for 2025 following its recent Q1 earnings report. This dynamic creates active community debate around ZBH's valuation and long-term growth trajectory within the competitive medical device sector.

VICI Properties, Inc. is a real estate investment trust, which owns, acquires and develops gaming, hospitality and entertainment properties. It operates through the following segments: Real Property Business and Golf Course Business. The Real Property Business segment consists of leased real property. The Golf Course Business segment consists of four golf courses. The company was founded on July 5, 2016 and is headquartered in New York, NY.

VICI Properties Inc

VICI Properties is trending as a high-quality experiential REIT, with recent positive earnings reports and strategic capital deployments reaffirming its robust business model. Community discussion highlights its strong dividend yield and inflation-protected leases on iconic gaming and entertainment assets as reasons to buy, particularly amidst current price levels which many view as an undervaluation. Investors are weighing VICI's defensive characteristics and steady income potential against broader market sentiment regarding REIT performance and anticipated shifts in interest rates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$HOOD

I discussed Robinhood&#39;s new product releases and pushed on whether the company can mix investing and gambling in the same app. Enjoy the interview! 

https://asymmetric-investing.beehiiv.com/p/asymmetric-interview-robinhood-s-head-of-product-abhishek-fatehpuria

Donna Walters

Alex

I talked with Robinhood's head of product about the company's vision, new AI features, and how prediction markets mix with investing.

Asymmetric Investing

Asymmetric Interview: Robinhood's Head of Product Abhishek Fatehpuria

beehiiv

Robinhood Markets Inc



I discussed Robinhood's new product releases and pushed on whether the company can mix investing and gambling in the same app. Enjoy the interview! 

